Abstract Details

Title Long-Term Safety And Tolerability Of Escalating Doses Of Crenezumab In Patients With Mild-To-Moderate Alzheimer’s Disease

Topic Aging and Dementia

Presentation(s) P6 - (-)

Poster/Presentation
Number 083

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Helen C. Lin, MD	Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
Michael Rabbia	No disclosure on file
Susanne Ostrowitzki, MD, PhD	No disclosure on file
Jillian Smith	Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
William Cho	No disclosure on file

��ɫ��